Marc Espié
Université Paris Cité(FR)Saint Louis University Hospital(US)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Saint-Louis(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Lesions and Carcinomas, Medical Imaging Techniques and Applications
Most-Cited Works
- → Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial(2017)467 cited
- → Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer(2010)396 cited
- → Phase I study of oxaliplatin in patients with advanced cancer(1990)339 cited
- → 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial(2013)337 cited
- → Performance of FDG PET/CT in the Clinical Management of Breast Cancer(2012)266 cited
- → Molecular Profiling of Inflammatory Breast Cancer(2004)255 cited